Table 1.
Effect of short-chain fatty acids on body weight, organ weight (relative to body weight), glucose, and non-esterified fatty acid (NEFA) concentrations. Data were analyzed using two-way ANOVA followed by Tukey’s post hoc test. Values are presented as mean ± SD. Different superscripts indicate significant difference amongst groups; only the male treatment (MT) group showed decrease in glucose levels. p < 0.05 was considered significant (n = 6). FC—female control, FT—female treatment, MC—male control, SCFAs—short-chain fatty acids.
| Parameter | MC | MT | FC | FT |
|---|---|---|---|---|
| Weight (g) | ||||
| Body weight (day 0) | 271.3 ± 17.58 a | 273.2 ± 10.65 a | 198.78 ± 6.02 b | 198.26 ± 7.73 b |
| Body weight (day 7) | 300.33 ± 18.79 a | 301.83 ± 8.57 a | 214 ± 7.72 b | 203.66 ± 5.58 b |
| Food intake | 23.00 ± 1.75 a | 22.33 ± 1.87 a | 14.60 ± 1.07 b | 14.80 ± 0.88 b |
| Liver | 12.58 ± 1.24 a | 12.72 ± 1.24 a | 8.49 ± 0.45 b | 8.97 ± 0.44 b |
| Abdominal fat | 2.03 ± 0.56 ab | 2.34 ± 0.43 a | 1.74 ± 0.28 ab | 1.43 ± 0.26 b |
| Concentration (mmol/L) | ||||
| Glucose | 6.38 a | 4.76 b | 5.52 b | 6.01 ab |
| NEFA | 0.42 | 0.39 | 0.37 | 0.34 |